​

Lisata Therapeutics (LSTA) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Lisata Therapeutics Revenue Highlights

Latest Revenue (Y)

$170.00K

Latest Revenue (Q)

$70.00K

Main Segment (Y)

Reportable Segment

Lisata Therapeutics Revenue by Period

Lisata Therapeutics Revenue by Year

DateRevenueChange
2025-12-31$170.00K-83.00%
2024-12-31$1.00M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--100.00%
2016-12-31$35.28M56.90%
2015-12-31$22.49M25.36%
2014-12-31$17.94M22.29%
2013-12-31$14.67M2.37%
2012-12-31$14.33M42.59%
2011-12-31$10.05M-85.61%
2010-12-31$69.82M503.73%
2009-12-31$11.56M13743.50%
2008-12-31$83.54K-63.94%
2007-12-31$231.66K406.66%
2006-12-31$45.72K29.67%
2005-12-31$35.26K-27.39%
2004-12-31$48.56K-24.87%
2003-12-31$64.63K-20.55%
2002-12-31$81.35K-24.29%
2001-12-31$107.45K-79.79%
2000-12-31$531.76K4036.90%
1999-12-31$12.85K100.00%
1998-12-31-100.00%
1997-03-31-100.00%
1996-03-31--100.00%
1995-03-25$21.05M177.34%
1994-03-27$7.59M2132.35%
1993-03-31$340.00K-

Lisata Therapeutics generated $170.00K in revenue during NA 2025, up -83.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Lisata Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30$70.00K100.00%
2025-03-31--100.00%
2024-12-31$1.00M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$121.37M100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--100.00%
2017-12-31$2.00K100.00%
2017-09-30-100.00%
2017-06-30--100.00%
2017-03-31$7.92M-22.15%
2016-12-31$10.18M9.22%
2016-09-30$9.32M12.25%
2016-06-30$8.30M10.83%
2016-03-31$7.49M-0.93%
2015-12-31$7.56M28.38%
2015-09-30$5.89M0.37%
2015-06-30$5.87M84.95%
2015-03-31$3.17M-39.88%
2014-12-31$5.28M28.14%
2014-09-30$4.12M-8.27%
2014-06-30$4.49M10.69%
2014-03-31$4.06M-0.56%
2013-12-31$4.08M141.32%
2013-09-30$1.69M-61.23%
2013-06-30$4.36M72.72%
2013-03-31$2.52M-8.26%
2012-12-31$2.75M-37.95%
2012-09-30$4.43M31.49%
2012-06-30$3.37M-84.71%
2012-03-31$22.06M23.50%
2011-12-31$17.86M0.58%
2011-09-30$17.76M-3.82%
2011-06-30$18.46M-6.01%
2011-03-31$19.64M8.48%
2010-12-31$18.11M9.89%
2010-09-30$16.48M-15.11%
2010-06-30$19.41M22.58%
2010-03-31$15.83M38.80%
2009-12-31$11.41M13309.91%
2009-09-30$85.07K169.20%
2009-06-30$31.60K-29.99%
2009-03-31$45.14K32.48%
2008-12-31$34.07K34.95%
2008-09-30$25.25K7.31%
2008-06-30$23.53K-

Lisata Therapeutics generated $70.00K in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Lisata Therapeutics Revenue Breakdown

Lisata Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24
Reportable Segment$170.00K$1.00M

Lisata Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 25: Reportable Segment (100.00%).

Lisata Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CLGNCollPlant Bio$10.96M$98.00K
LSTALisata Therapeutics$170.00K$70.00K
XCURExicure--
KLTOKlotho Neurosciences--
ENLVEnlivex Therapeutics--
NCNANuCana--
CLSDClearside Biomedical--
MTVAMetaVia--
PASGPassage Bio--

LSTA Revenue FAQ

What is Lisata Therapeutics’s yearly revenue?

Lisata Therapeutics's yearly revenue for 2025 was $170K, representing a decrease of -83.00% compared to 2024. The company's yearly revenue for 2024 was $1M, representing an increase of 100.00% compared to 2023. LSTA's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Lisata Therapeutics’s quarterly revenue?

Lisata Therapeutics's quarterly revenue for Q2 2025 was $70K, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). LSTA's quarterly revenue for Q4 2024 was $1M, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023).

What is Lisata Therapeutics’s revenue growth rate?

Lisata Therapeutics's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 0%.

What are Lisata Therapeutics’s revenue streams?

Lisata Therapeutics's revenue streams in c 25 are Reportable Segment

What is Lisata Therapeutics’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Lisata Therapeutics was Reportable Segment. This segment made a revenue of $170K, representing 100.00% of the company's total revenue.